Allowed positioning
Research intelligence, public monitoring, trial-change tracking, FDA-source watch, safety-signal screening, evidence-backed briefs.
Compliance posture
Public-data research intelligence, not a regulated pharmacovigilance workflow.
The safest MVP monitors public data, cites sources, and flags review-worthy movement without making medical, legal, regulatory, or causation claims.
Avoid positioning
Validated PV database, medical advice, regulatory reporting system, causation engine, incidence calculator, sponsor compliance guarantee.
Best buyer fit
Consultants, investors, research desks, law firms, market-access teams, smaller biotech operators, and competitive-intelligence users.
Suggested disclaimer
Clinical Trial Signal provides public-data research and business intelligence based on sources such as ClinicalTrials.gov, FDA, openFDA, FAERS, DailyMed, PubMed, EDGAR, and public sponsor disclosures. It is not medical advice, legal advice, regulatory advice, or a pharmacovigilance system of record. Adverse-event data may be incomplete, duplicated, unverified, and cannot establish causation or incidence. Signals shown here are intended for research screening and should be reviewed by qualified professionals.